More serious but less common adverse effects include pancreatitis, gallbladder disease, and acute kidney injury associated with severe gastrointestinal adverse effects and dehydration
Common Side Effects and Considerations Common side effects include mild-to-moderate gastrointestinal symptoms
Understanding Semaglutide and Its Benefits Semaglutide, an FDA-approved GLP-1 receptor agonist, is specifically designed for adults managing obesity or overweight conditions
After Your Treatment Unlike surgical weight loss treatments, semaglutide does not require any recovery or downtime
Knee pain and inflammation in the infrapatellar fat pad estimated by conventional and dynamic contrast-enhanced magnetic resonance imaging in obese patients with osteoarthritis: a cross-sectional study
A prescription is written, excitement builds, and then the price comes into focus, sometimes hundreds or even thousands of dollars, depending on coverage